(A) In vitro expressed and purified CDK9 was incubated with SUMO system components (SUMO4, E1, UBC9 and TRIM28) or left untreated. Five groups were set. Group 1 (G1): CDK9 only; Group 2 (G2): CDK9 and SUMO4; Group 3 (G3): CDK9, SUMO4 and E1 (SAE1 and UBA2); Group 4 (G4): CDK9, SUMO4, E1 and E2 (UBC9); Group 5 (G5): CDK9, SUMO4, E1, E2 and E3 (TRIM28). After in vitro SUMOylation, CDK9 substrate PDKtides and ATP were added and incubated for 120 min at room temperature. The ADP which was consumed during CDK9 kinase assay was converted to ATP and quantitated by luciferase assay.